Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Lu Liu, Minyue Yin, Jingwen Gao, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé‐Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation
Gaolong Zuo, Meiyan Chen, Yingpeng Zuo, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access | Times Cited: 16
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz‐López, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4387-4387
Open Access | Times Cited: 11
Recent advances in the application of microbial biosurfactants in food industries: Opportunities and challenges
Anushree Roy, Mojibur R. Khan, Ashis K. Mukherjee
Food Control (2024) Vol. 163, pp. 110465-110465
Closed Access | Times Cited: 10
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
Mi Zhou, Jianyu Lv, Han Y. H. Chen, et al.
Annals of Hepatology (2025), pp. 101777-101777
Open Access | Times Cited: 1
Probiotics for inflammatory bowel disease: Is there sufficient evidence?
Yueying Ma, Dandan Yang, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
Changrui Long, Xiaoyan Zhou, Fan Xia, et al.
Biology (2024) Vol. 13, Iss. 4, pp. 243-243
Open Access | Times Cited: 7
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease
Jakub Rochoń, Piotr Kalinowski, Ksenia Szymanek-Majchrzak, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 23, pp. 2964-2980
Open Access | Times Cited: 7
Intestinal changes in permeability, tight junction and mucin synthesis in a mouse model of Alzheimer's disease
Jing He, Yuanjie Liu, Junhua Li, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 6
Open Access | Times Cited: 13
Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease
Ana Isabel Vigil Medina, Mengdie Shi, Yanyan Wang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Advances in Nanotechnology for the Diagnosis and Management of Metabolic Dysfunction-associated Steatotic Liver Disease
Fenfen Li, Ruyan Yuan, Jiamin Zhang, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101025-101025
Open Access
Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review
Dorna Hashemi, Mohammad Vahedi Fard, Kimia Mohammadhasani, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 3
Open Access
Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis
Aysun Yakut
World Journal of Hepatology (2025) Vol. 17, Iss. 3
Closed Access
Baicalin alleviates lipid accumulation in adipocytes via inducing metabolic reprogramming and targeting Adenosine A1 receptor
Zaikuan Zhang, Runzhi Wang, Jin Cai, et al.
Toxicon (2025), pp. 108339-108339
Closed Access
Lactobacillus helveticus HY7804 Modulates the Gut–Liver Axis to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease in a Mouse Model
Hyeonji Kim, Hyejin Jeon, Ji-Woong Jeong, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3557-3557
Open Access
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
Emidio Scarpellini, Marialaura Scarcella, Jan Tack, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1386-1386
Open Access | Times Cited: 4
Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease: findings from the UK Biobank
Jia Yu, Dongze Li, Yi You, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Circulating Trimethylamine-N-Oxide Is Elevated in Liver Transplant Recipients
María Camila Trillos-Almanza, Mateo Chvatal-Medina, Margery A. Connelly, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6031-6031
Open Access | Times Cited: 1
Compound probiotics and glycyrrhizic acid alleviate DON-induced liver damage linked to the alteration of lipid metabolism in piglets
Mengjie Liu, Guorong Yan, Juan Chang, et al.
Journal of Functional Foods (2024) Vol. 120, pp. 106390-106390
Open Access | Times Cited: 1
Inulin alleviates inflammatory response and gut barrier dysfunction via modulating microbiota in lipopolysaccharide-challenged broilers
Qinghui Shang
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137208-137208
Closed Access | Times Cited: 1
Pharmacodynamic Material Basis of Licorice and Mechanisms of Modulating Bile Acid Metabolism and Gut Microbiota in Cisplatin-Induced Liver Injury based on LC-MS and Network Pharmacology Analysis
Jie Li, Xiaolong Lian, Baojian Li, et al.
Journal of Ethnopharmacology (2024), pp. 119293-119293
Closed Access | Times Cited: 1
The gut-mediated function of polyphenols: Opinions on functional food development for nonalcoholic fatty liver disease
Sunni Chen, Hong-Lin Zhu, Yangchao Luo
Current Opinion in Food Science (2022) Vol. 49, pp. 100972-100972
Closed Access | Times Cited: 6
Roles of gut microbes in metabolic-associated fatty liver disease
Chun‐Yao Chen, Han‐Chen Ho
Tzu Chi Medical Journal (2023)
Open Access | Times Cited: 2
Targeting gut microbiota and metabolism profiles with coated sodium butyrate to ameliorate high-energy and low-protein diet-induced intestinal barrier dysfunction in laying hens
Sasa Miao, Jiankui Li, Ying Chen, et al.
Animal nutrition (2024) Vol. 19, pp. 104-116
Open Access
Bile acid disorders and intestinal barrier dysfunction are involved in the development of fatty liver in laying hens
Lihua Zhao, Qiuyu Jiang, Jiaqi Lei, et al.
Poultry Science (2024) Vol. 103, Iss. 12, pp. 104422-104422
Open Access
Page 1 - Next Page

Scroll to top